Abstract
BackgroundTumor necrosis factor (TNF) inhibitors, including etanercept (ETN), have demonstrated efficacy in patients with non-radiographic axial spondyloarthritis (nr-axSpA) and an inadequate response to NSAIDs. However, not all patients respond to...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
